<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93989">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01778855</url>
  </required_header>
  <id_info>
    <org_study_id>HASTIER</org_study_id>
    <secondary_id>R01NS077706</secondary_id>
    <nct_id>NCT01778855</nct_id>
  </id_info>
  <brief_title>Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization</brief_title>
  <acronym>HASTIER</acronym>
  <official_title>An Ancillary Imaging Study to the Intravascular Cooling in the Treatment of Stroke 2 (ICTuS 2) Trial, an NIH-funded Project on the Safety and Efficacy of Hypothermia Combined With Thrombolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this Phase 2 HASTIER study, as an ancillary study to ICTuS 2, is to
      compare key imaging measurements for serial changes in recanalization and reperfusion
      between hypothermia and normothermia treatment arms as intermediate outcomes of treatment
      effect. Secondary exploratory analyses include imaging of the neurovascular impact of
      reperfusion with hypothermia and tPA, including blood-brain barrier changes or permeability,
      hemorrhagic transformation, and infarct growth.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective imaging ancillary study coincides with recruitment of ICTuS 2 by using
      currently available imaging tools at a subset of multicenter sites. HASTIER will evaluate
      therapeutic response with imaging outcome measures for recanalization and reperfusion. Key
      scientific objectives include the evaluation of hypothermia on benchmark recanalization and
      reperfusion rates in 120 cases of middle cerebral artery (MCA) stroke. Recanalization will
      be measured with Thrombolysis in Myocardial Infarction (TIMI) score change from baseline-36
      hour CT/MRI angiography. Reperfusion will be measured with Tmax &gt; 6s lesion volume change
      from baseline-36 hour CT/MRI perfusion imaging. Secondary outcomes will be measured with
      serial changes in permeability abnormalities derived from CT/MRI perfusion imaging,
      hemorrhagic transformation, and infarct growth from baseline-36 hours. Correlation of these
      imaging parameters with clinical outcomes will provide insight to accelerate research during
      these translational steps in hypothermia treatment for acute ischemic stroke.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Recanalization</measure>
    <time_frame>36 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine whether hypothermia alters recanalization with standard thrombolytic treatment with intravenous (IV) tissue plasminogen activator (tPA) for acute ischemic stroke in humans. The hypothesis is that hypothermia does not impair recanalization (opening of the artery). Recanalization will be measured with Thrombolysis in Myocardial Infarction (TIMI) score change from baseline angiography to 36 hour angiography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reperfusion</measure>
    <time_frame>36 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine whether hypothermia alters reperfusion with standard thrombolytic treatment with intravenous (IV) tissue plasminogen activator (tPA) for acute ischemic stroke in humans. The hypothesis is that hypothermia does not impair reperfusion (restoration of downstream flow) with thrombolysis. Reperfusion will be measured with Tmax &gt;6s lesion volume change from baseline perfusion imaging to 36 hour perfusion imaging.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurovascular impact of reperfusion with the combination of hypothermia and tPA.</measure>
    <time_frame>36 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The neurovascular impact of reperfusion will be measured by serial changes in permeability abnormalities derived from the CT/MR perfusion imaging, incidence of hemorrhagic transformation and infarct growth from baseline to 36 hours.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Normothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV t-PA and normothermia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV t-PA and hypothermia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV t-PA and normothermia</intervention_name>
    <arm_group_label>Normothermia</arm_group_label>
    <other_name>t-PA as standard of care and normothermia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IV-tPA and hypothermia</intervention_name>
    <arm_group_label>Hypothermia</arm_group_label>
    <other_name>Hypothermia is induced using the Celsius Controlâ„¢ System and IV-tPA administered</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible for inclusion in the ICTuS 2/3 trial.

          -  Diagnosis of MCA stroke, confirmed by M1 or M2 proximal MCA occlusion on CT/MRI
             angiography.

        Exclusion Criteria:

          -  Kidney dysfunction of such severity as to preclude routine administration of contrast
             media for CT/MRI angiography or perfusion imaging. Severe kidney dysfunction is
             defined by the American College of Radiology recommendations for use of contrast
             media.

          -  Known adverse reaction or allergy to such contrast media.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>82 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David S Liebeskind, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David S Liebeskind, MD</last_name>
    <phone>310-794-6379</phone>
    <email>davidliebeskind@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Teresa Rzesiewicz, RN, BSN, PHN, MBA, CCRC</last_name>
    <phone>858-657-7185</phone>
    <email>trzesiewicz@ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick D Lyden, MD</last_name>
      <phone>310-423-5166</phone>
      <email>patrick.lyden@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Patrick D Lyden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas M Hemmen, MD, PhD</last_name>
      <phone>858-657-7190</phone>
    </contact>
    <investigator>
      <last_name>Thomas M Hemmen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intercoastal Medical Group</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauricia Concha, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mauricia Concha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lyden PD, Allgren RL, Ng K, Akins P, Meyer B, Al-Sanani F, Lutsep H, Dobak J, Matsubara BS, Zivin J. Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis. 2005 May-Jun;14(3):107-14.</citation>
    <PMID>17904009</PMID>
  </reference>
  <reference>
    <citation>Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD; ICTuS-L Investigators. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke. 2010 Oct;41(10):2265-70. Epub 2010 Aug 19.</citation>
    <PMID>20724711</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>January 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>David Liebeskind</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>hypothermia</keyword>
  <keyword>thrombolysis</keyword>
  <keyword>imaging</keyword>
  <keyword>collateral circulation</keyword>
  <keyword>recanalization</keyword>
  <keyword>reperfusion</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
